gabapentin + estrogen

Gabapentin + estrogen is a non-standard, theoretical combination of two approved drugs—gabapentin and an estrogen (such as conjugated estrogens or estradiol)—sometimes considered for the management of menopausal symptoms, particularly hot flashes. Gabapentin is an anticonvulsant and structural analogue of gamma-aminobutyric acid (GABA), primarily used to treat neuropathic pain and partial seizures. It acts by modulating voltage-gated calcium channels in the central nervous system, reducing excitatory neurotransmitter release[1]. Estrogen refers to a group of steroid hormones that bind to and activate the estrogen receptor, regulating gene expression involved in reproductive tissues and other systems; it is commonly used as hormone replacement therapy for menopausal symptoms. Clinical studies have compared gabapentin monotherapy with estrogen monotherapy for hot flashes but there are no widely recognized fixed-dose combination products or clinical guidelines recommending their concurrent use as a single pharmaceutical product[2][3][5]. Both agents reduce vasomotor symptoms via different mechanisms—gabapentin through central thermoregulatory modulation, and estrogens through hormonal replacement.